Katsanis, E <br/><br/>
Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma.  [electronic resource] 

 -  Bone marrow transplantation  Jul 1998 
 - 185-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1701307  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Animals<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunotherapy, Adoptive<br/>Interleukin-2--administration & dosage<br/>Killer Cells, Natural--immunology<br/>Lymphoma, B-Cell--blood<br/>Mice<br/>Mice, SCID<br/>Neoplasms, Experimental--immunology<br/>Transplantation, Autologous